Bio-Rad Laboratories Inc. (BIO)
NYSE · Healthcare
Bio-Rad Laboratories Inc. Shareholder Equity 2008–2025
Bio-Rad Laboratories Inc. annual shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Bio-Rad Laboratories Inc. shareholder equity as of December 31, 2025: 7.45B, a 13.46% increase year-over-year.
- Bio-Rad Laboratories Inc. shareholder equity for 2025 were 7.45B, a 13.46% increase from 2024.
- Bio-Rad Laboratories Inc. shareholder equity for 2024 were 6.57B, a 24.85% decrease from 2023.
- Bio-Rad Laboratories Inc. shareholder equity for 2023 were 8.74B, a 9.09% decrease from 2022.
- Bio-Rad Laboratories Inc. shareholder equity for 2022 were 9.62B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bio-Rad Laboratories Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $7,454 |
| 2024 | $6,569 |
| 2023 | $8,741 |
| 2022 | $9,615 |
| 2021 | $13,685 |
| 2020 | $9,890 |
| 2019 | $5,757 |
| 2018 | $4,020 |
| 2017 | $2,930 |
| 2016 | $2,579 |
| 2015 | $2,485 |
| 2014 | $2,184 |
| 2013 | $2,187 |
| 2012 | $2,015 |
| 2011 | $1,744 |
Bio-Rad Laboratories Inc. Shareholder Equity — FAQ
Bio-Rad Laboratories Inc. (BIO) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIO's shareholder equity history?
The chart and table above show Bio-Rad Laboratories Inc.'s shareholder equity by year and by quarter, including the growth rate.